{"product_id":"9781298709035","title":"CFR 21, Parts 300 to 499, Food and Drugs, April 01, 2017 (Volume 5 of 9)","description":"\u003cp\u003eCode of Federal Regulations Title 21, Volume 5, April 1, 2017 contains regulations governing Food and Drugs and may also be referenced as:\u003c\/p\u003e\u003cp\u003e- Code of Federal Regulations Title 21, Volume 5, April 1, 2017\u003cbr\u003e- CFR Title 21\u003cbr\u003e- CFR 21, Food and Drugs\u003cbr\u003e- CFR 21, Parts 300 to 499, Food and Drugs\u003c\/p\u003e\u003cp\u003eThis volume contains Parts 300 to 499:\u003c\/p\u003e\u003cp\u003e- Part 300; GENERAL\u003cbr\u003e- Part 310; NEW DRUGS\u003cbr\u003e- Part 312; INVESTIGATIONAL NEW DRUG APPLICATION\u003cbr\u003e- Part 314; APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG\u003cbr\u003e- Part 315; DIAGNOSTIC RADIOPHARMACEUTICALS\u003cbr\u003e- Part 316; ORPHAN DRUGS\u003cbr\u003e- Part 317; QUALIFYING PATHOGENS\u003cbr\u003e- Part 320; BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS\u003cbr\u003e- Part 328; OVER-THE-COUNTER DRUG PRODUCTS INTENDED FOR ORAL INGESTION THAT CONTAIN ALCOHOL\u003cbr\u003e- Part 329; NONPRESCRIPTION HUMAN DRUG PRODUCTS SUBJECT TO SECTION 760 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT\u003cbr\u003e- Part 330; OVER-THE-COUNTER (OTC) HUMAN DRUGS WHICH ARE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED\u003cbr\u003e- Part 331; ANTACID PRODUCTS FOR OVER-THE-COUNTER (OTC) HUMAN USE\u003cbr\u003e- Part 332; ANTIFLATULENT PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 333; TOPICAL ANTIMICROBIAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 335; ANTIDIARRHEAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 336; ANTIEMETIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 338; NIGHTTIME SLEEP-AID DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 340; STIMULANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 341; COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 343; INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEU-MATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 344; TOPICAL OTIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 346; ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 347; SKIN PROTECTANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 348; EXTERNAL ANALGESIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 349; OPHTHALMIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 350; ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 352; SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY]\u003cbr\u003e- Part 355; ANTICARIES DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 357; MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 358; MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE\u003cbr\u003e- Part 361; PRESCRIPTION DRUGS FOR HUMAN USE GENERALLY RECOGNIZED AS SAFE AND EFFECTIVE AND NOT MISBRANDED: DRUGS USED IN RESEARCH\u003cbr\u003e- Part 369; INTERPRETATIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER-THE-COUNTER SALE\u003cbr\u003e- Parts 370-499; Reserved\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e","brand":"Creative Media Partners, LLC","offers":[{"title":"Default Title","offer_id":47046721241328,"sku":"9781298709035","price":34.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0737\/7593\/9824\/files\/9781298709035_p0.jpg?v=1763705344","url":"https:\/\/shop-qa.barnesandnoble.com\/products\/9781298709035","provider":"Barnes \u0026 Noble (DEV)","version":"1.0","type":"link"}